OncoMatch/Clinical Trials/NCT06559696

Internal Mammary Lymph Nodes Irradiation in High-risk Breast Cancer After Neoadjuvant Chemotherapy

Is NCT06559696 recruiting? Yes, currently enrolling (May 2026). This Phase 3 trial studies non-drug interventions for breast cancer.

Phase 3RecruitingFujian Medical University Union HospitalNCT06559696Data as of May 2026

The aim of this study is to explore the impact of internal mammary nodal irradiation on disease-free survival in high-risk breast cancer patients (ypN+or supra/subclavicular lymph node positive) after neoadjuvant chemotherapy.

Check if I qualify

Extracted eligibility criteria

Cancer type

Breast Carcinoma

Performance status

ECOG 0–2(Ambulatory, capable of self-care)

Prior therapy

Must have received: neoadjuvant chemotherapy — neoadjuvant

Underwent neoadjuvant chemotherapy

Cannot have received: neoadjuvant chemotherapy

Without neoadjuvant chemotherapy

Structured fields extracted by AI. May contain errors — verify against the official protocol.

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify